Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
BackgroundUnderstudied elderly patients comprise a large segment of high-risk patients with glioblastoma (GBM) that are challenging to treat. Tumor Treating Fields (TTFields) is a locoregional, noninvasive, antimitotic therapy delivering low-intensity, intermediate-frequency alternating electric fie...
Main Authors: | Zvi Ram, Chae-Yong Kim, Andreas F. Hottinger, Ahmed Idbaih, Garth Nicholas, Jay-Jiguang Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.671972/full |
Similar Items
-
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
by: N. Guberina, et al.
Published: (2020-04-01) -
The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
by: Liao KL, et al.
Published: (2018-06-01) -
Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
by: Felix Bokstein, et al.
Published: (2020-04-01) -
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
by: Mario E. Lacouture, et al.
Published: (2020-07-01) -
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
by: Roni Blatt, et al.
Published: (2021-06-01)